General Pathology & Immunology
Master high-yield cellular mechanisms, hypersensitivity cascades, immunodeficiency syndromes, transplant immunology, autoantibody diagnostics, and tumor genetics for board examination success.
Gell & Coombs Hypersensitivity Classification
Hypersensitivity reactions represent immunologic tissue damage caused by immune responses against environmental allergens, foreign antigens, or self-antigens. Master the classic mnemonic ACID: Anaphylactic (Type I), Cytotoxic / Cell-bound (Type II), Immune complex (Type III), and Delayed-type T-cell mediated (Type IV).
Immunological Mechanism Architecture
Vector SVG VisualizerImmediate (Anaphylactic & Atopic)
Key Mediators: IgE, Mast Cells, Basophils
Antigen cross-links preformed IgE bound to high-affinity FcεRI receptors on sensitized mast cells and basophils, triggering immediate degranulation of histamine, tryptase, and proteases. Late-phase response (2–8 hrs) mediated by leukotrienes (LTC4, LTD4, LTE4) and cytokines (IL-4, IL-5, IL-13) driving eosinophil recruitment.
High-Yield Clinical Exemplars
Acute hypotension, laryngeal edema, bronchospasm, urticaria. First-line Rx: IM Epinephrine (1:1000) anterolateral thigh.
Nasal mucosal edema, eosinophils in nasal discharge, allergic shiners.
Reversible bronchoconstriction, Curschmann spirals (mucus plugs), Charcot-Leyden crystals (eosinophil major basic protein).
Excess mast cells in marrow/organs; Darier sign (urticaria with skin rubbing); elevated serum tryptase.
Cytotoxic / Antibody-Mediated
Key Mediators: IgG, IgM against cell surface / ECM antigens
Antibodies bind to fixed cell-surface or tissue antigens. Three destructive pathways: (1) Complement activation via classical pathway (C3b opsonization & MAC lysis), (2) Antibody-Dependent Cellular Cytotoxicity (ADCC) via NK cells and macrophages (FcγR), and (3) Receptor dysfunction/stimulation without tissue damage.
High-Yield Clinical Exemplars
Linear IgG and C3 deposition along glomerular and alveolar basement membranes. Hemoptysis + rapidly progressive glomerulonephritis (RPGN).
Receptor antagonism/downregulation. Progressive muscle weakness worsening with use, ptosis, diplopia. Associated with thymoma.
Pathway activation independent of TSH. Hyperthyroidism, pretibial myxedema, exophthalmos.
Flaccid intraepidermal bullae, tombstone stratum basale, oral mucosal ulcers, (+) Nikolsky sign. Reticular / fishnet IF pattern.
Tense subepidermal bullae, spares oral mucosa, (-) Nikolsky sign. Linear IgG along dermal-epidermal junction.
Direct Coombs test (+). Warm AIHA: SLE, CLL; Cold AIHA: Mycoplasma pneumoniae, EBV mononucleosis.
Occurs within minutes of unclamping graft vessels. Thrombotic occlusion, graft ischemia/necrosis.
Immune Complex-Mediated
Key Mediators: Soluble Antigen-Antibody (IgG/IgM) Complexes + Complement
Circulating soluble antigen-antibody complexes form in slight antigen excess, escape reticuloendothelial clearance, and deposit in vascular basement membranes (renal glomeruli, synovia, dermal vessels). Complexes fix complement, releasing C3a and C5a (anaphylatoxins and neutrophil chemoattractants). Infiltrating neutrophils release lysosomal enzymes and ROS, producing fibrinoid necrosis.
High-Yield Clinical Exemplars
Lupus nephritis (diffuse proliferative GN with subendothelial wire-loop deposits), low C3/C4 levels, rash, arthritis.
2–4 weeks post-pharyngitis or impetigo. Granular "lumpy-bumpy" subepithelial humps on EM; cola-colored urine, low C3.
7–14 days post-exposure. Triad: Fever, urticaria/rash, arthralgias + lymphadenopathy and proteinuria. Low serum complement.
Transmural necrotizing inflammation of medium-sized arteries with fibrinoid necrosis; "string-of-pearls" microaneurysms on angiogram.
Local subacute immune complex deposition, dermal vessel thrombosis, and local tissue necrosis (e.g., booster tetanus vaccine).
Cell-Mediated (Delayed-Type / T-Cell)
Key Mediators: Sensitized T-Lymphocytes (CD4+ Th1/Th17 & CD8+ CTLs) — NO ANTIBODIES
Two distinct pathways: (1) Delayed-Type Hypersensitivity (DTH): Antigen presented by APCs on MHC II to CD4+ Th1 cells. Th1 cells release IFN-γ, which potently activates macrophages to secrete TNF-α and form granulomas. (2) Direct Cytotoxicity: CD8+ CTLs recognize foreign or modified intracellular antigens on MHC I and induce target cell apoptosis via perforin, granzyme B, and FasL.
High-Yield Clinical Exemplars
Pruritic erythematous papules and vesicles arranged in linear distributions corresponding to contact; spongiosis on biopsy.
Induration measured at 48–72 hours. Mediated by memory Th1 cells and recruited macrophages releasing TNF-α and IFN-γ.
Maculopapular rash (palms/soles), cholestatic jaundice (bile duct destruction), severe watery diarrhea.
Weeks to months post-transplant. Dense interstitial lymphocytic infiltrate with tubulitis/endothelialitis. Responsive to steroids.
Autoimmune demyelination mediated by T-cells and macrophage infiltration.